AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MESTEROLONE
10 registrations across 7 African markets— 9 active
Markets with MESTEROLONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Proviron 25 mg Tablet** Tablet | 🇳🇬Nigeria | Bayer Nigeria Limited | active | Feb 2028 |
| PROVIRON TABLET; ORAL | 🇿🇼Zimbabwe | BAYER (PTY) LTD | active | Dec 2027 |
| PROVIRON 25 MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| MESTEROLONE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| PROVIRON COMPRIME | 🇲🇦Morocco | — | active | — |
| Proviron Tablets | 🇹🇿Tanzania | Bayer East Africa Ltd | active | — |
| MESTEROLONE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| MESTEROLONE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| PROVIRON 25 MG COMPRIMÉ BOÎTE DE 20 | 🇨🇮Côte d'Ivoire | BAYER AG | active | — |
| MESTEROLONE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
MESTEROLONE in Africa — Regulatory Overview
MESTEROLONE is registered across 7 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Morocco, Malawi, Côte d'Ivoire and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.